149 related articles for article (PubMed ID: 17969413)
21. The epidemiology of bladder cancer in Russia.
Pushkar DY; Govorov AV; Matveev VB
Scand J Urol Nephrol Suppl; 2008 Sep; (218):21-4. PubMed ID: 18815913
[TBL] [Abstract][Full Text] [Related]
22. Urine concentration of nuclear matrix protein 22 for diagnosis of transitional cell carcinoma of bladder.
Jamshidian H; Kor K; Djalali M
Urol J; 2008; 5(4):243-7. PubMed ID: 19101898
[TBL] [Abstract][Full Text] [Related]
23. [Non-invasive molecular detection of bladder cancer].
Hatachmi S
Harefuah; 2009 Jan; 148(1):66-9, 86. PubMed ID: 19320394
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of urine tumor-associated trypsin inhibitor, CYFRA 21-1, and urinary bladder cancer antigen for detection of high-grade bladder carcinoma.
Gkialas I; Papadopoulos G; Iordanidou L; Stathouros G; Tzavara C; Gregorakis A; Lykourinas M
Urology; 2008 Nov; 72(5):1159-63. PubMed ID: 18514770
[TBL] [Abstract][Full Text] [Related]
25. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
Jancke G; Damm O; Rosell J; Jahnson S
Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
[TBL] [Abstract][Full Text] [Related]
27. [The role of low-field strength magnetic resonance imaging in bladder cancer staging].
Lutsenko PE; Bulanova TV; Chernyshev IV; Churaiants VV
Vestn Rentgenol Radiol; 2007; (2):46-51. PubMed ID: 18380198
[TBL] [Abstract][Full Text] [Related]
28. Computerized tomography for detecting perivesical infiltration and lymph node metastasis in invasive bladder carcinoma.
Baltaci S; Resorlu B; Yagci C; Turkolmez K; Gogus C; Beduk Y
Urol Int; 2008; 81(4):399-402. PubMed ID: 19077399
[TBL] [Abstract][Full Text] [Related]
29. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer.
Yu J; Zhu T; Wang Z; Zhang H; Qian Z; Xu H; Gao B; Wang W; Gu L; Meng J; Wang J; Feng X; Li Y; Yao X; Zhu J
Clin Cancer Res; 2007 Dec; 13(24):7296-304. PubMed ID: 18094410
[TBL] [Abstract][Full Text] [Related]
30. [Flow cytometry in urinary tract malignancies. I. Cytological diagnosis by DNA histogram of exfoliative cells in bladder cancer (author's transl)].
Akiyama T; Nagai N; Matsuura T; Iguchi M; Yachiku S; Kurita T
Nihon Hinyokika Gakkai Zasshi; 1981 Feb; 72(2):178-84. PubMed ID: 7019526
[No Abstract] [Full Text] [Related]
31. Urinary fibronectin as a predictor of a residual tumour load after transurethral resection of bladder transitional cell carcinoma.
Li LY; Yang M; Zhang HB; Su XK; Xu WF; Chen Y; Shen ZJ; Gao X
BJU Int; 2008 Aug; 102(5):566-71. PubMed ID: 18410436
[TBL] [Abstract][Full Text] [Related]
32. Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer.
Goh AC; Tresser NJ; Shen SS; Lerner SP
Urology; 2008 Jul; 72(1):133-7. PubMed ID: 18598789
[TBL] [Abstract][Full Text] [Related]
33. [Cancer of the bladder. Diagnosis and staging].
Smith PH; Green DF
Arch Esp Urol; 1982; 35(6):376-80. PubMed ID: 7165402
[No Abstract] [Full Text] [Related]
34. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
[TBL] [Abstract][Full Text] [Related]
35. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical detection of prostate-specific antigen expression in primary urothelial carcinoma of the urinary bladder.
Chen JC; Ho CL; Tsai HW; Tzai TS; Liu HS; Chow NH; Yang WH; Cheng HL
Anticancer Res; 2008; 28(6B):4149-54. PubMed ID: 19192675
[TBL] [Abstract][Full Text] [Related]
37. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.
Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS
BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151
[TBL] [Abstract][Full Text] [Related]
38. Transitional cell carcinoma of the urinary bladder: a clinicopathological study.
Matalka I; Bani-Hani K; Shotar A; Bani Hani O; Bani-Hani I
Singapore Med J; 2008 Oct; 49(10):790-4. PubMed ID: 18946612
[TBL] [Abstract][Full Text] [Related]
39. [Cytometry].
Seigneurin D
Ann Pathol; 2000; 20 Suppl():S86-7. PubMed ID: 11261308
[No Abstract] [Full Text] [Related]
40. [Value of impulse cytophotometry for the diagnosis and prognosis of bladder cancer].
Blech M; Zimmermann A; Truss F
Helv Chir Acta; 1982 Aug; 49(3-4):415-8. PubMed ID: 7129911
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
